Pharma is the strictest YMYL category Google evaluates. Without DR70+ editorial placements from medically credible publications, your pharmaceutical company's pages won't rank no matter how well-written they are. We build the authoritative backlink profiles that Google requires for medical and pharmaceutical content to surface in search.
14 Years
in link building
70K+
placements delivered
0
Google penalties
Pharmaceutical content faces the most stringent YMYL requirements in Google's quality guidelines. Your Money, Your Life isn't just a label — for pharma, it means Google explicitly evaluates the medical expertise, authoritativeness, and trustworthiness of every source before ranking it. A backlink from a low-authority site doesn't just fail to help — it can actively signal to Google that your site doesn't meet the threshold.
The regulatory dimension adds complexity. Pharmaceutical companies navigate FDA and international regulatory constraints on how drug information can be presented. Link building must stay within promotional guidelines while still building the editorial authority that SEO requires. Most link building agencies don't understand these constraints and produce placements that create compliance risk.
Competition comes from unexpected directions. Big Pharma brands like Pfizer and Merck have domain authorities above 85, but the more common challenge is competing against medical information sites like WebMD, Mayo Clinic, and Healthline — DR90+ publishers that dominate information queries. Your pipeline or company pages need substantial authority to appear alongside these resources.
Biotech and specialty pharma have unique challenges. Companies commercializing novel therapeutics face the additional hurdle of educating the market — building awareness in a space where the search volume for your specific drug category may be minimal but the lifetime patient value is enormous.
We build the medically credible editorial presence that Google's YMYL standards require for pharmaceutical content to rank. That means placements exclusively on publications with demonstrated medical or scientific authority — peer-reviewed adjacent outlets, health journalism platforms, biotech and life sciences trade publications, and respected medical news sites.
Anchor strategy for pharma clients is conservative by design. We prioritize branded company mentions and disease-area terms over product-specific anchors that could create regulatory issues. Building authority to corporate, research, and pipeline pages rather than direct drug promotion keeps placements compliant and effective.
We target DR65+ as an absolute minimum for pharma placements, with most landing at DR70-85. In a space where Google evaluates source authority with particular scrutiny, a smaller number of high-authority placements outperforms a larger volume of moderate-authority links.
Content we create focuses on company expertise, research leadership, and disease education — areas where pharmaceutical companies can build authoritative voices without promotional concerns. Pipeline research commentary, therapeutic area expertise, and health policy insights all earn legitimate editorial coverage from credible medical publications.
We audit your current backlink profile against pharma industry standards, identifying both DR gaps and any compliance risks in existing links. We map the medical and life sciences publications that drive authority for your therapeutic areas.
We match your company to medically credible publications, biotech trade outlets, health journalism platforms, and life sciences industry media based on your therapeutic focus and DR targets. Every publication passes a medical credibility review.
Our writers create expert commentary on therapeutic trends, pipeline research insights, and health policy analysis that passes both editorial review and stays within pharmaceutical promotional guidelines.
You get a live dashboard showing every placement with DR, anchor text, and indexing status. We track visibility improvements for your corporate and research pages monthly and report on medical authority metrics.
High
medical authority threshold met
10-15
DR70+ medical placements
6-9 months
typical timeline
Here's what a typical engagement looks like for clients in the pharmaceutical and biotech space. A specialty pharma or biotech company typically comes to us needing to establish organic visibility for their corporate presence, pipeline communications, or therapeutic area education content. Their challenge isn't content quality — it's that Google applies such stringent authority requirements to medical content that only links from genuinely credible medical publications move the needle.
Over a 6-9 month engagement, we build a foundation of placements on life sciences trade publications, health journalism outlets, and biotech industry media. Content focuses on therapeutic expertise, pipeline commentary, and health policy insights that position the company as a credible scientific voice. The result is improved visibility for corporate and pipeline-related queries, with each placement also serving as a credibility signal with the healthcare professionals, analysts, and investors who research pharmaceutical companies.
Companies in this space typically see meaningful improvements in branded search authority and category visibility within 6 months, with the most significant gains on therapeutic area and disease education pages.
Position your medical leadership and research teams as therapeutic area experts with contributions on health journalism platforms and life sciences publications. Disease area insights, treatment landscape analysis, and clinical research commentary.
“CMO commentary on emerging oncology treatment approaches for a leading health journalism platform”
Get editorial coverage for your research milestones and pipeline developments on biotech and life sciences trade publications. We pitch to editors who cover pharmaceutical innovation with genuine scientific credibility.
“Coverage of Phase III trial results in a DR78 life sciences trade publication”
Original analysis of healthcare policy, drug pricing trends, or patient access issues earns links from publications covering health policy. Turn your company's perspective on healthcare issues into cited research.
“Healthcare access report cited by 10+ health journalism and policy publications”
Strategic contributions on health consumer publications covering disease awareness, treatment options, and patient resources. Content that serves patients while building authority for disease-area keywords.
“Patient education piece on disease management published on a DR72 health consumer platform”
928+
Publishers Available
DA 67
Average Domain Authority
410
DA 70+ Publishers
1.7B
Combined Monthly Traffic
For pharmaceutical clients, we apply the most stringent publication selection criteria in our network. Placements land exclusively on publications with demonstrable medical or scientific credibility — health journalism platforms, biotech and life sciences trade media, medical news outlets, and healthcare industry publications with established editorial standards and medical reviewer processes.
We do not place pharmaceutical content on general tech blogs, business directories, or publications without medical editorial oversight. Every placement is evaluated for both DR and medical credibility. You can review our pharmaceutical-approved publisher list in the self-serve portal.
Most link building agencies are not equipped to work in the pharmaceutical space. They don't understand YMYL requirements, FDA promotional guidelines, or the difference between medical authority and general domain authority. The result is placements that either fail to help or create compliance exposure.
We work exclusively within medically credible publications and keep every placement within pharmaceutical promotional norms. Our pharma clients get the DR70+ editorial placements from legitimate medical and life sciences outlets that actually move rankings — without compliance risk.
With 14 years and 70K+ placements, we have developed specific expertise in YMYL industries including pharmaceutical, medical device, and healthcare. Our track record of zero Google penalties reflects the editorial standards we apply even in the most scrutinized content categories.
Pharmaceutical SEO requires a different standard of link building. DR70+ placements from medically credible publications are the only links that move the needle for YMYL medical content.